GlaxoSmithKline PLC (GSK) Stake Reduced by HL Financial Services LLC

HL Financial Services LLC lowered its position in GlaxoSmithKline PLC (NYSE:GSK) by 2.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 62,005 shares of the pharmaceutical company’s stock after selling 1,646 shares during the period. HL Financial Services LLC’s holdings in GlaxoSmithKline PLC were worth $2,674,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of GSK. FMR LLC increased its position in shares of GlaxoSmithKline PLC by 11.7% in the first quarter. FMR LLC now owns 23,635,038 shares of the pharmaceutical company’s stock worth $996,452,000 after buying an additional 2,482,009 shares during the last quarter. Fisher Asset Management LLC increased its position in shares of GlaxoSmithKline PLC by 4.7% in the second quarter. Fisher Asset Management LLC now owns 12,534,385 shares of the pharmaceutical company’s stock worth $540,483,000 after buying an additional 564,519 shares during the last quarter. Bank of America Corp DE increased its position in shares of GlaxoSmithKline PLC by 15.8% in the first quarter. Bank of America Corp DE now owns 6,849,632 shares of the pharmaceutical company’s stock worth $288,780,000 after buying an additional 934,928 shares during the last quarter. Renaissance Technologies LLC increased its position in shares of GlaxoSmithKline PLC by 42.7% in the first quarter. Renaissance Technologies LLC now owns 4,402,100 shares of the pharmaceutical company’s stock worth $185,593,000 after buying an additional 1,316,600 shares during the last quarter. Finally, Brandes Investment Partners LP increased its position in shares of GlaxoSmithKline PLC by 6.8% in the first quarter. Brandes Investment Partners LP now owns 3,363,788 shares of the pharmaceutical company’s stock worth $141,817,000 after buying an additional 214,167 shares during the last quarter. Institutional investors and hedge funds own 8.96% of the company’s stock.

Shares of GlaxoSmithKline PLC (GSK) opened at 39.53 on Thursday. The stock has a 50 day moving average of $42.13 and a 200-day moving average of $41.86. The company has a market cap of $96.61 billion, a PE ratio of 38.23 and a beta of 1.03. GlaxoSmithKline PLC has a 12 month low of $37.20 and a 12 month high of $44.59.

GlaxoSmithKline PLC (NYSE:GSK) last announced its quarterly earnings data on Wednesday, July 26th. The pharmaceutical company reported $0.70 earnings per share for the quarter, topping the consensus estimate of $0.68 by $0.02. GlaxoSmithKline PLC had a return on equity of 114.93% and a net margin of 6.48%. The company had revenue of $9.36 billion during the quarter, compared to analyst estimates of $9.52 billion. Equities analysts forecast that GlaxoSmithKline PLC will post $2.85 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 12th. Investors of record on Friday, August 11th will be issued a $0.491 dividend. The ex-dividend date of this dividend is Wednesday, August 9th. This represents a $1.96 annualized dividend and a yield of 4.97%. This is a positive change from GlaxoSmithKline PLC’s previous quarterly dividend of $0.46. GlaxoSmithKline PLC’s dividend payout ratio (DPR) is 194.00%.

TRADEMARK VIOLATION NOTICE: “GlaxoSmithKline PLC (GSK) Stake Reduced by HL Financial Services LLC” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/2798716/glaxosmithkline-plc-gsk-stake-reduced-by-hl-financial-services-llc.html.

A number of equities analysts have commented on GSK shares. Zacks Investment Research cut shares of GlaxoSmithKline PLC from a “buy” rating to a “hold” rating in a research report on Friday, July 21st. J P Morgan Chase & Co reaffirmed a “neutral” rating on shares of GlaxoSmithKline PLC in a research report on Monday, July 24th. ValuEngine cut shares of GlaxoSmithKline PLC from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. BidaskClub cut shares of GlaxoSmithKline PLC from a “sell” rating to a “strong sell” rating in a research report on Monday, July 24th. Finally, Berenberg Bank raised shares of GlaxoSmithKline PLC from a “hold” rating to a “buy” rating in a research report on Friday, May 26th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $46.00.

GlaxoSmithKline PLC Company Profile

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

Want to see what other hedge funds are holding GSK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GlaxoSmithKline PLC (NYSE:GSK).

Institutional Ownership by Quarter for GlaxoSmithKline PLC (NYSE:GSK)

Receive News & Ratings for GlaxoSmithKline PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.